Apollon Formularies PLC APOL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Apollon Formularies PLC is a London, England and Jamaican based medical cannabis pharmaceutical company specialising in research and treatment of patients with cancer and chronic pain. It is engaged in investing by seeking to acquire a direct and/or indirect interest in projects and assets in the agriculture and logistics sectors and the medicinal cannabis sector. The company focus on opportunities in Africa and Europe. It has created proprietary hybrid medical cannabis pharmaceutical strains, technology, formulations, and treatment products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- —
- Website
- https://www.apollon.org.uk
Valuation
|
Metric
|
APOL
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
APOL
Financial Strength
|
Metric
|
APOL
|
|---|---|
Quick Ratio | 0.40 |
Current Ratio | 0.60 |
Interest Coverage | — |
Quick Ratio
APOL
Profitability
|
Metric
|
APOL
|
|---|---|
Return on Assets (Normalized) | −36.65% |
Return on Equity (Normalized) | −40.62% |
Return on Invested Capital (Normalized) | −39.91% |
Return on Assets
APOL
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Zgnbzdmjs | Jylbb | $79.4 Bil | |
MKKGY
| Merck KGaA ADR | Hhzcyhtfx | Cbmhd | $79.0 Bil | |
HLN
| Haleon PLC ADR | Yzftvtn | Qqjnz | $38.5 Bil | |
VTRS
| Viatris Inc | Cylgnjlv | Jltg | $13.1 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Ccvxqlpy | Hmvb | $11.7 Bil | |
CTLT
| Catalent Inc | Vmrjfhn | Tfnljx | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Fbmhbdg | Kqrch | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Kqhgjdwyd | Smvh | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Fgvfkqnwc | Ymfzfzt | $3.2 Bil | |
GTBIF
| Green Thumb Industries Inc | Fyskbvvtr | Zvjg | $3.1 Bil |